HLK Pharmacin

company

About

HLK Pharmacin is committed to improving patient outcomes through the development of best-in-class therapeutics.

  • 1 - 10

Details

Last Funding Type
Series B
Industries
Pharmaceutical
Founded date
Jan 1, 2011
Number Of Employee
1 - 10
Operating Status
Active

Funding Rounds

Number of Funding Rounds
Total Funding Amount
1
HLK Pharmacin has raised a total of — in funding over 2 rounds. Their latest funding was raised on Aug 31, 2021 from a Series B round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Aug 31, 2021 Series B 2 Detail

Investors

Number of Lead Investors
Number of Investors
2
HLK Pharmacin is funded by 2 investors. Qingdao Medicine and DaYou Capital are the most recent investors.
Investor Name Lead Investor Funding Round
Qingdao Medicine Series B
DaYou Capital Series B